Oncimmune Holdings plc announced that Martin Gouldstone has started as the Company's new Chief Executive Officer and joined the Board of Directors. With Martin as Chief Executive Officer, Ron Kirschner, who was appointed as acting Chief Executive Officer in June, will be taking up the role of Chief Operating Officer and has stepped down from the Board. Ron remains Oncimmune's Company Secretary.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23 GBX | -2.13% | -16.67% | -8.73% |
Feb. 29 | EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout | AN |
Feb. 29 | Oncimmune Holdings plc Provides Earnings Guidance for the Year 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.73% | 21.23M | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
+18.82% | 2.38B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B |
- Stock Market
- Equities
- ONC Stock
- News Oncimmune Holdings plc
- Oncimmune Holdings plc Announces Executive Changes